RNA Dividend: Avidity Biosciences Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	20	10	9	9	9	6
Revenue Growth (YoY)	100%	11%	0%	0%	50%	200%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	145	86	54	37	26	13
Research & Development	488	303	190	150	101	37
Operating Expenses	633	389	245	188	127	51
Other Non Operating Income (Expenses)	-1	0	0	0	0	0
Pretax Income	-549	-322	-212	-174	-118	-44
Income Tax Expense	--	0	--	--	--	--
Net Income	-549	-322	-212	-174	-118	-44
Net Income Growth	96%	52%	22%	47%	168%	83%
Shares Outstanding (Diluted)	137.89	111.58	73.01	52.16	41.43	37.57
Shares Change (YoY)	12%	53%	40%	26%	10%	-15%
EPS (Diluted)	-3.98	-2.88	-2.9	-3.34	-2.85	-1.18
EPS Growth	75%	-1%	-13%	17%	142%	111%
Free Cash Flow	-595	-307	-123	-139	-98	-38
Free Cash Flow Per Share	-4.31	-2.75	-1.68	-2.66	-2.36	-1.01
Gross Margin	--	--	--	--	--	--
Operating Margin	-3,060%	-3,779.99%	-2,611.11%	-1,977.77%	-1,311.11%	-733.33%
Profit Margin	-2,745%	-3,220%	-2,355.55%	-1,933.33%	-1,311.11%	-733.33%
Free Cash Flow Margin	-2,975%	-3,070%	-1,366.66%	-1,544.44%	-1,088.88%	-633.33%
EBITDA	-609	-376	-233	-177	-118	-44
EBITDA Margin	-3,045%	-3,760%	-2,588.88%	-1,966.66%	-1,311.11%	-733.33%
D&A For EBITDA	3	2	2	1	0	0
EBIT	-612	-378	-235	-178	-118	-44
EBIT Margin	-3,060%	-3,779.99%	-2,611.11%	-1,977.77%	-1,311.11%	-733.33%
Effective Tax Rate	--	0%	--	--	--	--

Avidity Biosciences Inc (RNA) Price